ECHA Launches Public Consultation on Three New SVHC Candidate Substances

Time: Mar 7, 2025
欧盟
SVHCs

On February 28, 2025, the European Chemicals Agency (ECHA) initiated a public consultation under the EU’s REACH Regulation (Registration, Evaluation, Authorization, and Restriction of Chemicals) regarding proposals to list three substances as Substances of Very High Concern (SVHCs). Stakeholders may submit scientific or technical comments by April 14, 2025.

1,1,1,3,5,5,5-heptamethyl-3-[(trimethylsilyl)oxy]trisiloxane 241-867-7 17928-28-8 vPvB (Article 57e) 14/04/2025
decamethyltetrasiloxane 205-491-7 141-62-8 vPvB (Article 57e) 14/04/2025
tetra(sodium/potassium) 7-[(E)-{2-acetamido-4-[(E)-(4-{[4-chloro-6-({2-[(4-fluoro-6-{[4-(vinylsulfonyl)phenyl]amino}-1,3,5-triazine-2-yl)amino]propyl}amino)-1,3,5-triazine-2-yl]amino}-5-sulfonato-1-naphthyl)diazenyl]-5-methoxyphenyl}diazenyl]-1,3,6-naphthalenetrisulfonate; Reactive Brown 51 466-490-7 - Toxic for reproduction (Article 57c) 14/04/2025

Obligations for Companies When Products Contain SVHCs

  1. Provide Safety Data Sheets (SDS) to downstream users when SVHCs are sold individually.
  2. Provide SDS if SVHCs are present in mixtures at concentrations ≥0.1%.
  3. Provide detailed information free of charge within 45 days to downstream users or consumers if SVHCs exceed 0.1% (w/w) in articles.
  4. Notify ECHA within six months if an article contains >0.1% (w/w) of a single SVHC and annual export volume exceeds 1 ton.
  5. Submit SCIP notifications for articles containing SVHCs >0.1% since January 5, 2021, in compliance with the EU Waste Framework Directive (WFD).

ChemRadar Insights

SVHCs typically include CMR 1A/1B substances (carcinogenic, mutagenic, or toxic to reproduction), PBTs (persistent, bioaccumulative, and toxic), vPvBs (very persistent and very bioaccumulative), and substances with equivalent hazards (e.g., endocrine disruptors). These substances are often considered potential candidates for the REACH Authorization List. Once listed as SVHCs, the likelihood of their eventual inclusion in the Authorization List increases significantly.

 

Further Information

ECHA

Disclaimer
1.
CIRS aims to keep the content of this site accurate and up to date. However, CIRS makes no warranties or representations regarding the quality, accuracy, completeness or reliability of information on the site.
2.
In no event shall CIRS assume or have any responsibility or liability for any information on this site or for any claims, damages or losses resulting from their use.
3.
CIRS reserves the right, at our discretion, to change, modify, add to, or remove portions of information on this site at any time without notice.
Feedbacks
Service Hotline